Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “de Novo Kidney Transplantation”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00257387
What this trial is testing

Study Evaluating Cyclosporine Dose Reduction and Cyclosporine Elimination in Chinese Kidney Transplants

Who this might be right for
Kidney Transplant
Wyeth is now a wholly owned subsidiary of Pfizer 120
Post-approval studies (Phase 4)Study completedNCT00154206
What this trial is testing

Study of Enteric-coated Mycophenolate Sodium (EC-MPS) With Cyclosporine Microemulsion and Steroids in Pediatric de Novo Renal Transplant Patients

Who this might be right for
Kidney Transplantation
Novartis Pharmaceuticals 15
Not applicableStudy completedNCT00079222
What this trial is testing

Voriconazole Compared With Itraconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Cancer
Jonsson Comprehensive Cancer Center
Large-scale testing (Phase 3)Study completedNCT00149929
What this trial is testing

Follow-up Study of Safety of Enteric-coated Mycophenolate Sodium in Patients Who Successfully Completed Study CERL080A301

Who this might be right for
Renal Transplant
Novartis 246
Not applicableStudy completedNCT01496417
What this trial is testing

Belatacept in Renal Transplantation With Intermediate Risk Maryland Aggregate Pathology Index (MAPI) Scores

Who this might be right for
End-Stage Renal Disease
University of Maryland 20
Large-scale testing (Phase 3)Study completedNCT00238940
What this trial is testing

Extension Study of Enteric-coated Mycophenolate Sodium in Combination With Full Dose or Reduced Dose Cyclosporine Microemulsion in Patients With de Novo Kidney Transplants

Who this might be right for
Renal Transplantation
Novartis 55
Testing effectiveness (Phase 2)Study completedNCT00078858
What this trial is testing

Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell Transplant

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+132 more
Fred Hutchinson Cancer Center 37
Post-approval studies (Phase 4)Study completedNCT00261820
What this trial is testing

Study Comparing Two Immunosuppressive Regimens in De Novo Renal Allograft Recipients

Who this might be right for
Graft RejectionKidney FailureKidney Transplantation
Wyeth is now a wholly owned subsidiary of Pfizer 160
Post-approval studies (Phase 4)Study completedNCT00565474
What this trial is testing

Evaluation of the Effect of Fluvastatin 40 mg (b.i.d.) in the Prevention of the Development of Vasculopathy of the Graft in de Novo Renal Transplant Patients Transplant

Who this might be right for
Graft Vasculopathy
Novartis Pharmaceuticals 84
Post-approval studies (Phase 4)Study completedNCT00171496
What this trial is testing

Evaluation of Cyclosporine Microemulsion and Tacrolimus on the Rate of New Onset Diabetes Mellitus in Kidney Transplantation Recipients

Who this might be right for
Kidney Transplant
Novartis 693
Not applicableEnded earlyNCT01609673
What this trial is testing

Study of Everolimus in de Novo Renal Transplant Recipients

Who this might be right for
End Stage Renal Failure With Renal Transplant
Helady Pinheiro, MD, PhD 1
Testing effectiveness (Phase 2)Study completedNCT03663335
What this trial is testing

Study of Efficacy, Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) of an Anti-CD40 Monoclonal Antibody, CFZ533, in Kidney Transplant Recipients

Who this might be right for
Kidney Transplantation
Novartis Pharmaceuticals 418
Early research (Phase 1)Study completedNCT00509691
What this trial is testing

Vaccine Therapy in Treating Patients Who Have Undergone a Donor Stem Cell Transplant and Have Cytomegalovirus Infection That Has Not Responded to Therapy

Who this might be right for
Cancer
University of Louisville 20
Large-scale testing (Phase 3)Study completedNCT01025817
What this trial is testing

Non-inferiority Study of Safety and Efficacy of Everolimus With Low Dose Tacrolimus to Mycophenolate Mofetil With Standard Dose Tacrolimus in Kidney Transplant Recipients

Who this might be right for
Kidney Transplant
Novartis Pharmaceuticals 613
Early research (Phase 1)Study completedNCT00569283
What this trial is testing

Donor Natural Killer Cell Infusion in Preventing Relapse or Graft Failure in Patients Who Have Undergone Donor Bone Marrow Transplant

Who this might be right for
Cancer
Asan Medical Center 18
Testing effectiveness (Phase 2)Study completedNCT00003887
What this trial is testing

Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
Fred Hutchinson Cancer Center
Post-approval studies (Phase 4)Study completedNCT02084446
What this trial is testing

Everolimus + Very Low Tacrolimus vs Enteric-coated Mycophenolate Sodium + Low Tacrolimus in de Novo Renal Transplant

Who this might be right for
Transplantation InfectionCytomegalovirus Infections
Ronaldo de Matos Esmeraldo, MD 120
Testing effectiveness (Phase 2)Study completedNCT00787761
What this trial is testing

Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological Cancer

Who this might be right for
Myeloproliferative DisordersKidney CancerLeukemia+4 more
Northside Hospital, Inc. 24
Testing effectiveness (Phase 2)Study completedNCT00365287
What this trial is testing

Combination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney Cancer

Who this might be right for
Breast CancerKidney CancerLeukemia+3 more
Masonic Cancer Center, University of Minnesota 148
Post-approval studies (Phase 4)Study completedNCT01950819
What this trial is testing

Advancing Renal TRANSplant eFficacy and Safety Outcomes With an eveRolimus-based regiMen (TRANSFORM)

Who this might be right for
End Stage Renal Disease (ESRD)Chronic Kidney Disease (CKD)Hemodialysis+2 more
Novartis Pharmaceuticals 2,037
Next Page